Confirmation of 99T’s efficacy found in long term Clostridium Difficile Infection (CDI) incidence monitoring study in tertiary hospital



Dr. Adriano Anesi, Clinical Microbiologist at the Lodi Hospital complex, has presented the results of a study designed to monitor the levels of CDI incidence in various hospitals’ wards before and after the introduction of our surface disinfection technology. By using a breakpoint time series analysis model, significant contractions were detected in the monthly CDI rate after that our disinfection technology was fully embedded into routine hygiene practices. Potential bias factors, such as seasonal CD incidence variations, were fully monitored and accounted for, and corroborated the fact that the important decrease in CDI were attributable solely to the introduction of the use of our disinfection systems. Click here to see the presentation and learn more.   

Our Corporate Responsibility

In our daily strive to reduce the burden of Health Care Acquired Infections we partner with non profit organizations active in helping financially challenged institutions. Learn how in the CSR dedicated section of our website.


If you have a solid experience in the marketing of new products and introducing novel technologies, you might be the person/organization we wish to have on our side as a distributor in your country. Please visit the Distributors' section of our website by clicking on the little yellow button below on the right to learn more.

Contact Us

If you have an immediate question you wish to ask us, please click on the yellow button below to the right, and fill out the short form.